Kazuki Suruga

Kazuki Suruga

Auto-generated profile, based on publicly available information

Kazuki Suruga

Cedars‐Sinai Medical Center, Smidt Heart Institute

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2023 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
MKMisaki Kanezawa
Misaki Kanezawa
HSHiroto Shimokawahara
Hiroto Shimokawahara
MTMasahiro Tsuji
Masahiro Tsuji
KSKazuki Suruga
Kazuki Suruga
AMAyane Miyagi
Ayane Miyagi
HMHiromi Matsubara
Hiromi Matsubara
Peripheral pulmonary arterial stenosis (PPAS) is commonly observed in paediatric patients with associated congenital heart disease or systemic congenital syndromes, such as tetralogy of Fallot and Williams syndrome [1]. Meanwhile, isolated PPAS without other structural heart disease or systemic congenital syndromes is primarily reported in adulthood [2]. Recent genetic analyses have revealed that four cases of isolated PPAS in adulthood were homozygous for the ring finger protein 213 (RNF213) p.Arg4810Lys variant (also referred to as G to A alteration of rs112735431 and NM_001256071.3:c.14429G>A) [3]. RNF213 p.Arg4810Lys is a genetic determinant in moyamoya disease (MMD) in East Asians [4]. This genetic variant is unique to East Asians and is reported to have a frequency of approximately 0.8% in the general Japanese population [5, 6]. However, its prevalence in adult patients with isolated PPAS remains unknown.

23 June 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
KSKazuki Suruga
Kazuki Suruga
VPVivek Patel
Vivek Patel
TNTakashi Nagasaka
Takashi Nagasaka
YGYuchao Guo
Yuchao Guo
PMPrateek Madaan
Prateek Madaan
RMRaj R. Makkar
Raj R. Makkar

16 March 2021 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
KSKazuki Suruga
Kazuki Suruga
KSKazuyoshi Suenari
Kazuyoshi Suenari
TNTakayuki Nakano
Takayuki Nakano
HTHajime Takemoto
Hajime Takemoto
YHYuu Hashimoto
Yuu Hashimoto
HIHiroshi Ito
Hiroshi Ito

9 December 2023 in Canadian Journal of Cardiology
Verified
Journal Article
Open access
KSKazuki Suruga
Kazuki Suruga
HSHiroto Shimokawahara
Hiroto Shimokawahara
AMAyane Miyagi
Ayane Miyagi
YSYoichi Sugiyama
Yoichi Sugiyama
TSTakeshi Suetomi
Takeshi Suetomi
HMHiromi Matsubara
Hiromi Matsubara
The number of successfully recanalized total occlusions affects hemodynamic improvement after balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to clarify the current efficacy, patency, and success rate of BPA for total occlusions. Between April 2016 and August 2021, 178 BPAs were performed in 100 patients with CTEPH and total occlusions. The primary success and subsequent patency rates immediately before the second BPA procedure (follow-up) were compared between the segmental and subsegmental groups, based on the flow grade, which was defined as follows: 0, no reperfusion; 1, minimal reperfusion; 2, partial reperfusion; and 3, complete reperfusion. Total occlusions were mainly located in the right lung (70%) and lower lobes (48%). The primary success rate was 88%, with significant improvements in oxygenation, hemodynamic parameters, and 6-minute walk test. The primary flow grade did not differ between groups. However, the proportion of lesions with a flow grade of 2 or 3 at follow-up was significantly higher in the subsegmental group than in the segmental group (84% vs 45%, respectively; P < 0.01). In multivariate analysis, flow grade in the acute phase (odds ratio [OR], 46.9; 95% confidence interval [CI], 12.54-176.78; P < 0.01) and subsegmental lesions (OR, 13.8; 95% CI, 3.24-58.94; P < 0.01) were independently associated with better patency (flow grade of 2 or 3) at follow-up. Total occlusions can be safely and effectively treated with BPA. BPA for total occlusions may be preferable for subsegmental over segmental lesions.

22 November 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
Alon ShechterAlon Shechter
Alon Shechter
HTHoma Taheri
Homa Taheri
TNTakashi Nagasaka
Takashi Nagasaka
AGAakriti Gupta
Aakriti Gupta
DKDanon Kaewkes
Danon Kaewkes
RMRaj R. Makkar
Raj R. Makkar
Background: Prognostically meaningful tricuspid regurgitation (TR) is not well‐defined in the mitral transcatheter edge‐to‐edge repair arena. We aimed to explore the prevalence, correlates, and consequences of TR grades and postprocedural trends in this setting. Methods and Results: A single‐center registry of isolated, first‐time interventions was retrospectively assessed for pre‐, intra‐, and postprocedural aspects up to 1 year, of them the primary composite outcome of all‐cause deaths or heart failure (HF) hospitalizations, all according to TR severity at baseline and at 1 month following mitral transcatheter edge‐to‐edge repair. Overall, 1287 individuals (60.3% men, age 78 [interquartile range, 69–85] years, 52.9% with functional mitral regurgitation) were included. Below‐moderate, moderate, and above‐moderate TR affected 48.4%, 29.5%, and 22.1% of patients, respectively. Increasing TR severity was accompanied by higher rates of functional, severe mitral regurgitation, greater comorbidity, and more advanced heart failure. Although not affecting technical and echocardiographic procedural success, moderate‐and‐above TR degrees were associated with higher incidence of mortality, heart failure admissions, and functional class III to IV postprocedure, with moderate‐to‐severe and greater TR independently conferring increased risk for the various outcomes (primary end point; HR, 1.36 [95% CI, 1.21–1.80]; P =0.027). One‐month postprocedural TR severity directly correlated with, and was mostly similar to or worse than, its baseline counterpart. Rather than the change between the two, moderate‐and‐above grade at 1 month, observed in 37.1% of eligible cases, emerged as predictive of the primary outcome's risk. Conclusions: Among patients undergoing mitral transcatheter edge‐to‐edge repair, above‐moderate TR at baseline and the closely related moderate‐and‐above TR at 1 month postprocedure are highly prevalent and signal a suboptimal course.

5 May 2026 in JACC: Cardiovascular Interventions
Verified
Journal Article
Open access
DDDanny Dvir
Danny Dvir
HJHasan Jilaihawi
Hasan Jilaihawi
IKIkki Komatsu
Ikki Komatsu
ATAnna Turyan
Anna Turyan
RJRami Jubeh
Rami Jubeh
CDCreighton Don
Creighton Don